Alzheimer’s Disease Market Infographic
Nov 29, 2019
It’s is the end of Alzheimer’s Awareness Month, but our hope for a cure for this disease will not end.
They may not remember us, but we need to remember that Alzheimer’s battle is not theirs alone, but all of ours.
Downloads
Article in PDF
Recent Articles
- Gilead’s remdesivir trials; F2G raises $60.8M; Cancer immunotherapy research updates; Celle...
- The Question That Remains Unanswered: What Might Be Causing Alzheimer’s?
- Amylyx Raises $30M; QurAlis Announces License Agreement Deal With Lilly; COVID-19 Vaccine Updates...
- An Ageing Population and Upcoming Therapies: What is shaping the Alzheimer’s Disease Market Scena...
- The Road Ahead for Donanemab: Will the Therapy be the Next Imminent Breakthrough in the Alzheimer...
Downloads
Article in PDF
Recent Articles
- Gilead’s remdesivir trials; F2G raises $60.8M; Cancer immunotherapy research updates; Celle...
- An Ageing Population and Upcoming Therapies: What is shaping the Alzheimer’s Disease Market Scena...
- Neuroscience Highlights – 17/07/2018
- A New Dawn in Alzheimer’s Disease Treatment: Eli Lilly’s Donanemab Wins FDA Approval
- Can Alzheimer’s be cured with Marijuana?
